We are live on
!
Find out more
BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.97B
1-Year Est. Return
44.96%
This Fund
S&P 500
This Quarter
Est. Return
+9.43%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$4.21B
AUM Growth
+$243M
(+6.1%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.3%
Top 10 Holdings %
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$20.5M |
| 2 |
Netflix
NFLX
|
+$19.9M |
| 3 |
Costco
COST
|
+$18.6M |
| 4 |
IBM
IBM
|
+$17.9M |
| 5 |
Palantir
PLTR
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$19.1M |
| 2 |
Qualcomm
QCOM
|
+$19.1M |
| 3 |
Comcast
CMCSA
|
+$19.1M |
| 4 |
Intel
INTC
|
+$19.1M |
| 5 |
United Parcel Service
UPS
|
+$19M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.41% |
| 2 | Consumer Discretionary | 12.53% |
| 3 | Industrials | 11.69% |
| 4 | Technology | 11.48% |
| 5 | Energy | 9.24% |
Similar funds
MOS
CFC
SNT
MA
FFB
AM
SGM
CCA
Bridgeway Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Bridgeway Capital Management held 1,288 positions worth $4.21B, up 6.1% from $3.97B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Bridgeway Capital Management's Q2 2025 filing shows 116 new, 426 increased, 381 reduced and 108 closed positions. Its largest new stake was AbbVie: 110,140 shares worth $20.4M. The largest sale was Pfizer, an estimated $19.1M.
By sector, the portfolio is most concentrated in Financials at 28% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Bridgeway Capital Management's largest Q2 2025 buy was AbbVie: 110,140 shares worth $20.4M.
- Bridgeway Capital Management added most to Costco in Q2 2025, an estimated $18.6M increase.
- Bridgeway Capital Management's biggest Q2 2025 reduction was Gulfport Energy Corp, cutting an estimated $14.8M.
- Bridgeway Capital Management fully exited Pfizer in Q2 2025, selling an estimated $19.1M.
- Bridgeway Capital Management's ten largest holdings make up 8.2% of its $4.21B portfolio in Q2 2025.
- Bridgeway Capital Management opened 116 new positions and closed 108 in Q2 2025.
- Bridgeway Capital Management's portfolio value rose 6.1% quarter-over-quarter to $4.21B.
Based on Bridgeway Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.